Showing results (511-520 of 548) with videos related to

Sort By:
Pageof 55
The Journal of Clinical Investigation|September 20, 2024
Long-lived lung megakaryocytes contribute to platelet recovery in thrombocytopenia modelsAlison C Livada, Kathleen E McGrath, Michael W Malloy, et al.
The Journal of Burn Care & Rehabilitation|June 7, 2003
Current management of purpura fulminans: a multicenter studyP M Warner, R J Kagan, K P Yakuboff, et al.
Cells|March 10, 2022
Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral AdrenoleukodystrophyHongge Wang, Matthew D Davison, Martin L Kramer, et al.
Cardiology in Review|March 10, 2023
Complication Rates Following Cerebral and Coronary Angiography: Nationwide Analysis 2008-2014Justin M Lapow, Rajkumar S Pammal, Martina Brozynski, et al.
Journal of Virology|November 13, 2009
Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolutionVictoria Kasprowicz, Yu-Hoi Kang, Michaela Lucas, et al.
The Journal of Experimental Medicine|January 4, 2012
Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistenceJulian Schulze Zur Wiesch, Donatella Ciuffreda, Lia Lewis-Ximenez, et al.
Blood Advances|August 27, 2021
An irradiated marrow niche reveals a small noncollagenous protein mediator of homing, dermatopontinAshley C Kramer, Yuliana Astuti, Alexis Elfstrum, et al.
Journal of Medicinal Chemistry|September 19, 2012
Spirocyclic sulfamides as β-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer's disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitorsMichael A Brodney, Gabriela Barreiro, Kevin Ogilvie, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|October 5, 2001
DSM-IV internal construct validity: when a taxonomy meets dataC A Hartman, J Hox, G J Mellenbergh, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 8, 2012
Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analysesYasong Lu, David Riddell, Eva Hajos-Korcsok, et al.
Pageof 55